AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
INTERLEUKIN-1-BETA COMPLETELY PROTECTS MICE FROM LETHAL CHALLENGE WITH ANTI-FAS BY REDUCING HEPATOCYTE APOPTOSIS
Authors: TAKEBARA T HAYASHI N TATSUMI T KANTO T MITA E SASAKI Y KASAHARA A HORI M
Citation: T. Takebara et al., INTERLEUKIN-1-BETA COMPLETELY PROTECTS MICE FROM LETHAL CHALLENGE WITH ANTI-FAS BY REDUCING HEPATOCYTE APOPTOSIS, Hepatology, 28(4), 1998, pp. 642-642
INFLUENCE OF TTV INFECTION ON THE CLINICAL-FEATURES AND THE RESPONSE TO INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: HAGIWARA H HAYASHI N MITA E OSHITA M KOBAYASHI I IIO S HIRAMATSU N SASAKI Y KASAHARA A KAKINUMA K YAMAUCHI T FUSAMOTO H
Citation: H. Hagiwara et al., INFLUENCE OF TTV INFECTION ON THE CLINICAL-FEATURES AND THE RESPONSE TO INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 828-828
ACTIVATION OF INTERFERON SYSTEM TRIGGERED BY DOUBLE-STRANDED-RNA INDUCES APOPTOSIS IN HEPATOCELLULAR-CARCINOMA DERIVED CELL-LINES
Authors: KANAZAWA Y HAYASHI N UEDA K ISHIDA H IIO S OHKAWA K NAKANISHI F MITA E SASAKI Y HORI M
Citation: Y. Kanazawa et al., ACTIVATION OF INTERFERON SYSTEM TRIGGERED BY DOUBLE-STRANDED-RNA INDUCES APOPTOSIS IN HEPATOCELLULAR-CARCINOMA DERIVED CELL-LINES, Hepatology, 28(4), 1998, pp. 1074-1074
INFLUENCE OF HLA HAPLOTYPES ON THE EFFICACY OF INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: OSHITA M KUZUSHITA N HIRAMATSU N OHKAWA K MOCHIZUKI K KANTO T MITA E KUBO M ASAI A TANIMURA H ABE T ENOMOTO N FUJIMOTO K HOSUI A SATO A OKADA N NANIYO A MIYATAKE H SASAKI Y KASAHARA A MASUZAWA M HAYASHI N
Citation: M. Oshita et al., INFLUENCE OF HLA HAPLOTYPES ON THE EFFICACY OF INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 1252-1252
A NOVEL HEPATOCYTE-SPECIFIC TRANSCRIPTION FACTOR MIGHT CONTROL HEPATITIS-B VIRUS ENHANCER-II
Authors: ISHIDA H HAYASHI N UEDA K IIO S KANAZAWA Y OHKAWA K NAKANISHI F MITA E SASAKI Y KASAHARA A HORI M
Citation: H. Ishida et al., A NOVEL HEPATOCYTE-SPECIFIC TRANSCRIPTION FACTOR MIGHT CONTROL HEPATITIS-B VIRUS ENHANCER-II, Hepatology, 28(4), 1998, pp. 1283-1283
A GENE THERAPEUTIC APPROACH USING AN ENCAPSIDATION SIGNAL-EPSILON DECOY SUPPRESSES HEPATITIS-B VIRUS-REPLICATION
Authors: OHKAWA K HAYASHI N UEDA K YUKI N ISHIDA H LIO S KANAZAWA Y MITA E NAKANISHI F SASAKI Y KASAHARA A HORI M
Citation: K. Ohkawa et al., A GENE THERAPEUTIC APPROACH USING AN ENCAPSIDATION SIGNAL-EPSILON DECOY SUPPRESSES HEPATITIS-B VIRUS-REPLICATION, Hepatology, 28(4), 1998, pp. 1697-1697
DELAYED FAS-MEDIATED HEPATOCYTE APOPTOSIS DURING LIVER-REGENERATION IN MICE - HEPATOPROTECTIVE ROLE OF TNF-ALPHA
Authors: TAKEHARA T HAYASHI N MITA E KANTO T TATSUMI T SASAKI Y KASAHARA A HORI M
Citation: T. Takehara et al., DELAYED FAS-MEDIATED HEPATOCYTE APOPTOSIS DURING LIVER-REGENERATION IN MICE - HEPATOPROTECTIVE ROLE OF TNF-ALPHA, Hepatology, 27(6), 1998, pp. 1643-1651
SERUM LEVELS OF SOLUBLE FAS ANTIGEN IN CHRONIC HEPATITIS-C PATIENTS
Authors: IIO S HAYASHI N MITA E UEDA K MOCHIZUKI K HIRAMATSU N KANTO T SASAKI Y KASAHARA A HORI M
Citation: S. Iio et al., SERUM LEVELS OF SOLUBLE FAS ANTIGEN IN CHRONIC HEPATITIS-C PATIENTS, Journal of hepatology, 29(4), 1998, pp. 517-523
GBV-C HGV INFECTION IN CHRONIC HEPATITIS-C PATIENTS - ITS EFFECT ON CLINICAL-FEATURES AND INTERFERON THERAPY/
Authors: OSHITA M HAYASHI N MITA E IIO S HIRAMATSU N HIJIOKA T KATO M MASUZAWA M SASAKI Y KASAHARA A HORI M
Citation: M. Oshita et al., GBV-C HGV INFECTION IN CHRONIC HEPATITIS-C PATIENTS - ITS EFFECT ON CLINICAL-FEATURES AND INTERFERON THERAPY/, Journal of medical virology, 55(2), 1998, pp. 98-102
EFFECTS OF NIFEDIPINE AND KRN2391 ON THE HYPERACTIVE URINARY-BLADDER INDUCED BY CEREBRAL-ISCHEMIA IN RATS
Authors: NAKAMURA Y YOKOYAMA O KOMATSU K ISHIURA Y MITA E NAMIKI M TSUJI T KONTANI H
Citation: Y. Nakamura et al., EFFECTS OF NIFEDIPINE AND KRN2391 ON THE HYPERACTIVE URINARY-BLADDER INDUCED BY CEREBRAL-ISCHEMIA IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4120-4120
EFFECTS OF MK-801 ON BLADDER OVERACTIVITY IN RATS WITH CEREBRAL INFARCTION
Authors: YOKOYAMA O ISHIURA Y KOMATSU K MITA E NAKAMURA Y KUNIMI K MORIKAWA K NAMIKI M
Citation: O. Yokoyama et al., EFFECTS OF MK-801 ON BLADDER OVERACTIVITY IN RATS WITH CEREBRAL INFARCTION, The Journal of urology, 159(2), 1998, pp. 571-576
SEQUENCING ANALYSIS OF THE TERMINAL PROTEIN REGION IN PATIENTS SHOWING PERSISTENT REMISSION OF CHRONIC HEPATITIS-B
Authors: OHKAWA K HAYASHI N YUKI N MITA E MIYAMOTO Y KATAYAMA K KASAHARA A KATO M MASUZAWA M FUSAMOTO H KAMADA T
Citation: K. Ohkawa et al., SEQUENCING ANALYSIS OF THE TERMINAL PROTEIN REGION IN PATIENTS SHOWING PERSISTENT REMISSION OF CHRONIC HEPATITIS-B, HEPATOLOGY RESEARCH, 7(3), 1997, pp. 168-177
FAS SYSTEM AND APOPTOSIS IN VIRAL-HEPATITIS
Authors: HAYASHI N MITA E
Citation: N. Hayashi et E. Mita, FAS SYSTEM AND APOPTOSIS IN VIRAL-HEPATITIS, Journal of gastroenterology and hepatology, 12(9-10), 1997, pp. 223-226
BLADDER COMPLIANCE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Authors: YOKOYAMA O MITA E ISHIURA Y NAKAMURA Y NAGANO KI NAMIKI M
Citation: O. Yokoyama et al., BLADDER COMPLIANCE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, Neurourol. urodyn., 16(1), 1997, pp. 19-27
DELAYED APOPTOTIC DEATH PROCESS OF HEPATOCYTES MEDIATED BY FAS DURINGLIVER-REGENERATION
Authors: TAKEHARA T HAYASHI N TATSUMI T YAMAMOTO M KANTO T MITA E SASAKI Y KASAHARA A HORI M
Citation: T. Takehara et al., DELAYED APOPTOTIC DEATH PROCESS OF HEPATOCYTES MEDIATED BY FAS DURINGLIVER-REGENERATION, Hepatology, 26(4), 1997, pp. 1929-1929
B7 BB-1 EXPRESSION AND HEPATITIS ACTIVITY IN LIVER-TISSUES OF PATIENTS WITH CHRONIC HEPATITIS-C/
Authors: MOCHIZUKI K HAYASHI N KATAYAMA K HIRAMATSU N KANTO T MITA E TATSUMI T KUZUSHITA N KASAHARA A FUSAMOTO H YOKOCHI T KAMADA T
Citation: K. Mochizuki et al., B7 BB-1 EXPRESSION AND HEPATITIS ACTIVITY IN LIVER-TISSUES OF PATIENTS WITH CHRONIC HEPATITIS-C/, Hepatology, 25(3), 1997, pp. 713-718
CLEAVAGE OF VIRAL-RNA AND INHIBITION OF VIRAL TRANSLATION BY HEPATITIS-C VIRUS RNA-SPECIFIC HAMMERHEAD RIBOZYME IN-VITRO
Authors: OHKAWA K YUKI N KANAZAWA Y UEDA K MITA E SASAKI Y KASAHARA A HAYASHI N
Citation: K. Ohkawa et al., CLEAVAGE OF VIRAL-RNA AND INHIBITION OF VIRAL TRANSLATION BY HEPATITIS-C VIRUS RNA-SPECIFIC HAMMERHEAD RIBOZYME IN-VITRO, Journal of hepatology, 27(1), 1997, pp. 78-84
HEPATITIS-C VIRUS REPLICATIVE LEVELS AND EFFICIENCY OF GENOTYPING BY SPECIFIC PCR AND ANTIBODY-ASSAY
Authors: YUKI N HAYASHI N MITA E HAGIWARA H OHKAWA K KATAYAMA K SASAKI Y KASAHARA A FUSAMOTO H KAMADA T
Citation: N. Yuki et al., HEPATITIS-C VIRUS REPLICATIVE LEVELS AND EFFICIENCY OF GENOTYPING BY SPECIFIC PCR AND ANTIBODY-ASSAY, Journal of clinical microbiology, 35(5), 1997, pp. 1184-1189
URODYNAMIC EFFECTS OF INTRAVESICAL INSTILLATION OF LIDOCAINE IN PATIENTS WITH OVERACTIVE DETRUSOR
Authors: YOKOYAMA O ISHIURA Y NAKAMURA Y KUNIMI K MITA E NAMIKI M
Citation: O. Yokoyama et al., URODYNAMIC EFFECTS OF INTRAVESICAL INSTILLATION OF LIDOCAINE IN PATIENTS WITH OVERACTIVE DETRUSOR, The Journal of urology, 157(5), 1997, pp. 1826-1830
RIBOZYME-MEDIATED INHIBITION OF HUMAN TELOMERASE ACTIVITY IN EXTRACTSOF HEPATOCELLULAR-CARCINOMA DERIVED LINES
Authors: KANAZAWA Y OHKAWA K UEDA K MITA E SASAKI Y KASAHARA A HAYASHI N
Citation: Y. Kanazawa et al., RIBOZYME-MEDIATED INHIBITION OF HUMAN TELOMERASE ACTIVITY IN EXTRACTSOF HEPATOCELLULAR-CARCINOMA DERIVED LINES, Cancer gene therapy, 3(6), 1996, pp. 95-95
HEPATITIS-G VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: OSHITA M MITA E IIO S UEDA K ISHIDA H SASAKI Y KASAHARA A HAYASHI N
Citation: M. Oshita et al., HEPATITIS-G VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 24(4), 1996, pp. 404-404
INHIBITION OF HUMAN TELOMERASE ACTIVITY IN EXTRACTS OF HEPATOCELLULAR-CARCINOMA CELLS BY HAMMERHEAD RIBOZYME
Authors: KANAZAWA Y OHKAWA K UEDA K MITA E SASAKI Y KASAHARA A HAYASHI N
Citation: Y. Kanazawa et al., INHIBITION OF HUMAN TELOMERASE ACTIVITY IN EXTRACTS OF HEPATOCELLULAR-CARCINOMA CELLS BY HAMMERHEAD RIBOZYME, Hepatology, 24(4), 1996, pp. 541-541
ELEVATED SERUM LEVEL OF SOLUBLE FAS ANTIGEN IN CHRONIC HEPATITIS-B AND HEPATITIS-C PATIENTS
Authors: IIO S MITA E MOCHIZUKI K UEDA K KATAYAMA K SASAKI Y KASAHARA A HAYASHI N
Citation: S. Iio et al., ELEVATED SERUM LEVEL OF SOLUBLE FAS ANTIGEN IN CHRONIC HEPATITIS-B AND HEPATITIS-C PATIENTS, Hepatology, 24(4), 1996, pp. 1597-1597
QUANTITATIVE-ANALYSIS OF ANTIBODY TO HEPATITIS-C VIRUS ENVELOPE-2 GLYCOPROTEIN IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION
Authors: YUKI N HAYASHI N KASAHARA A HAGIWARA H MITA E OHKAWA K KATAYAMA K FUSAMOTO H KAMADA T
Citation: N. Yuki et al., QUANTITATIVE-ANALYSIS OF ANTIBODY TO HEPATITIS-C VIRUS ENVELOPE-2 GLYCOPROTEIN IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION, Hepatology, 23(5), 1996, pp. 947-952
RETREATMENT WITH 24-WEEK COURSE OF NATURAL INTERFERON-ALPHA FOR PATIENTS WITH CHRONIC HEPATITIS-C
Authors: HAGIWARA H HAYASHI N OSHITA M MITA E NAITO M KANTO T MOCHIZUKI K KUZUSHITA N KATAYAMA K KASAHARA A FUSAMOTO H KAMADA T
Citation: H. Hagiwara et al., RETREATMENT WITH 24-WEEK COURSE OF NATURAL INTERFERON-ALPHA FOR PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 23(1), 1996, pp. 127-127
Risultati: 1-25 | 26-50 | 51-72